These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 6988473)
1. Current concepts in the classification of connective tissue diseases. Overlap syndromes and mixed connective tissue disease (MCTD). Sharp GC; Anderson PC J Am Acad Dermatol; 1980 Apr; 2(4):269-79. PubMed ID: 6988473 [TBL] [Abstract][Full Text] [Related]
2. An external validation study of a classification of mixed connective tissue disease and systemic lupus erythematosus patients. Hoffman RW; Bezruczko N; Perkins K J Appl Meas; 2012; 13(2):205-16. PubMed ID: 22805362 [TBL] [Abstract][Full Text] [Related]
3. [Sharp's syndrome. Clinical, immunological and nosographic aspects]. Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. Amigues JM; Cantagrel A; Abbal M; Mazieres B J Rheumatol; 1996 Dec; 23(12):2055-62. PubMed ID: 8970041 [TBL] [Abstract][Full Text] [Related]
5. The diagnosis and classification of mixed connective tissue disease. Tani C; Carli L; Vagnani S; Talarico R; Baldini C; Mosca M; Bombardieri S J Autoimmun; 2014; 48-49():46-9. PubMed ID: 24461387 [TBL] [Abstract][Full Text] [Related]
6. Can SLE classification rules be effectively applied to diagnose unclear SLE cases? Mesa A; Fernandez M; Wu W; Narasimhan G; Greidinger EL; Mills DK Lupus; 2017 Feb; 26(2):150-162. PubMed ID: 27353506 [TBL] [Abstract][Full Text] [Related]
7. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Dima A; Jurcut C; Baicus C Rheumatol Int; 2018 Jul; 38(7):1169-1178. PubMed ID: 29796907 [TBL] [Abstract][Full Text] [Related]
8. [Undifferentiated, overlapping and mixed connective tissue diseases]. Ruiz Pombo M; Labrador Horrillo M; Selva O'Callaghan A Med Clin (Barc); 2004 Nov; 123(18):712-7. PubMed ID: 15563821 [TBL] [Abstract][Full Text] [Related]
9. [Mixed connective tissue disease: progress in diagnosis and treatment. II. Physiopathology and diagnosis. 6. Overlap syndrome and MCTD]. Akizuki M Nihon Naika Gakkai Zasshi; 1996 Aug; 85(8):1223-7. PubMed ID: 8965018 [No Abstract] [Full Text] [Related]
17. Facts and controversies in mixed connective tissue disease. Martínez-Barrio J; Valor L; López-Longo FJ Med Clin (Barc); 2018 Jan; 150(1):26-32. PubMed ID: 28864092 [TBL] [Abstract][Full Text] [Related]
18. Is MCTD a distinct entity? Comparison of clinical and laboratory findings in MCTD, SLE, PSS, and RA patients. De Clerck LS; Meijers KA; Cats A Clin Rheumatol; 1989 Mar; 8(1):29-36. PubMed ID: 2743718 [TBL] [Abstract][Full Text] [Related]
20. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens. Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]